<html>

<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0,user-scalable=0" />

<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_Footer&action=raw&ctype=text/css" />
<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_Footer_Icons&action=raw&ctype=text/css" />
<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_InPageMenu&action=raw&ctype=text/css" />
<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_MainContent&action=raw&ctype=text/css" />

<link rel="stylesheet" type="text/css"
    href="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/CSS_NavBar&action=raw&ctype=text/css" />
<script type="text/javascript"
    src="https://2021.igem.org/wiki/index.php?title=Template:Greece_United/JS_NavBar&action=raw&ctype=text/javascript">
</script>
<script src="https://2021.igem.org/common/MathJax-2.5-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<!-- clear default settings -->
<style>
    /* CLEAR DEFAULT SETTINGS **************************************************/

    #sideMenu,
    #top_title,
    .patrollink,
    #firstHeading,
    #home_logo,
    #sideMenu {
        display: none;
    }

    #content {
        padding: 0px;
        width: 100%;
        margin-top: 7px;
        margin-left: 0px;
        border: none;
    }

    #bodyContent h1,
    #bodyContent h2,
    #bodyContent h3,
    #bodyContent h4,
    #bodyContent h5 {
        margin-bottom: 0px;
    }

    #bodyContent a[href ^="https://"],
    .link-https {
        padding-right: 0px;
    }

    html {
        height: 100%;
        min-height: 100%;
        font-family: 'Raleway', sans-serif;

    }

    body {
        padding: 0px;
        margin: 0px;
        background: white;

        font-family: 'Raleway', sans-serif;

        display: flex;
        flex-direction: column;
    }
</style>

<!-- general -->
<style>
    .p {
        text-align: justify;
    }

    .banner {
        width: 100%;
        background-size: cover;
        margin-top: 100px;
        z-index: 10;
    }
</style>

<!-- loader -->
<style>
    #loader-wrapper {
        display: flex;
        align-items: center;
        margin-top: calc((100%)/5);
        justify-content: center;
        height: 0.1vh;
        width: 100vw;
        z-index: 500;
        position: fixed;
        pointer-events: none;
    }

    #loader-bg {
        position: fixed;
        height: 200vw;
        width: 200vw;
        transform: translateY(0);
        background-color: #6C8EC9;
        transition-property: height, width, border-radius, transform;
        transition-duration: 0.5s;
        transition-timing-function: cubic-bezier(.99, .05, .51, 1.01);
        transition-delay: 0s, 0s, 0s, 1s;
        border-radius: 0%;
        -webkit-box-shadow: 0px 0px 27px 0px #6E91CB;
        -moz-box-shadow: 0px 0px 27px 0px #6E91CB;
        box-shadow: 0px 0px 27px 0px #6E91CB;
        justify-content: center;
        align-items: center;
        display: flex;
        flex-direction: column;
        overflow: hidden;
    }


    #loader-wrapper img {
        width: 30vh;

    }

    #loader-wrapper h1 {
        color: #fafafc;
        text-transform: uppercase;
        font-family: 'montserrat-black', sans-serif !important;
        position: absolute;
        transform: translateY(15vh);
        font-size: 2.2vw;
        opacity: 100%;
    }

    #loader-bg.loaded {
        height: 35vh;
        width: 35vh;
        border-radius: 70%;
        transform: translateY(-2000px);
    }
</style>

<!-- nav bar -->
<style>
    /* Navigation Bar */
    /* -------------- NAVBAR ------------ */
    .right-navbar {
        align-self: flex-end;
        /* overflow: hidden;  */
        margin-left: auto;
        margin-right: 15px;
        cursor: pointer;
    }

    /* Style the navigation bar links */
    .right-navbar a {
        float: right;
        /* Make sure that the links stay side-by-side */
        display: block;
        /* Change the display to block, for responsive reasons (see below) */
        color: white;
        /* White text color */
        text-align: center;
        /* Center the text */
        padding: 14px 20px;
        /* Add some padding */
        text-decoration: none;
        /* Remove underline */
        font-size: 1.2em;
        /* overflow: hidden; */
    }

    #nav {
        display: flex;
        flex-direction: row;
        list-style: none inside;
        margin: 0;
        padding: 0;
    }

    #nav li {
        display: block;
    }

    #nav li li a {
        font-size: 90%;
    }

    #nav ul {
        padding: 0;
        display: none;
    }

    #nav li:hover ul {
        display: block;
    }

    .right-navbar a:hover,
    .dropdown:hover {
        background-color: #B7E0FF;
        /* Grey background color */
        color: #002060;
        /* Black text color */
        pointer-events: visible;
    }

    /* Header */
    .circles {
        background-image: url("https://2021.igem.org/wiki/images/1/16/T--Greece_United--header.png");
        background-size: cover;
        opacity: 80%;
        margin: 0;
        width: 100%;
        background-repeat: no-repeat;
    }

    .dropdown-content {
        display: none;
        position: absolute;
        background-color: #B7E0FF;
        opacity: 80%;
        min-width: 160px;
        box-shadow: 0px 8px 16px 0px rgba(0, 0, 0, 0.2);
        z-index: 10;
    }

    .dropdown-content a {
        float: none;
        color: #002060;
        padding: 14px 18px;
        text-decoration: none;
        display: block;
        text-align: left;
    }

    .dropdown-content a:hover {
        background-color: #5893D4;
        color: #002060;
    }


    .dropdown:hover .dropdown-content {
        display: block;
    }
</style>

<!-- progress bar -->
<style>
    #fixedOverlay {
        position: fixed;
        height: 100%;
        width: 100%;
        z-index: 12;
        top: 18px;
        transition: 1s;
        font-family: "montserrat-light" !important;
        /* background-color: #002060; */
    }

    #fixedOverlay[bg=none],
    #fixedOverlay[bg=dark] {
        pointer-events: none;
    }

    #fixedOverlay .scroll-wrapper {
        display: flex;
        position: fixed;
        width: 100%;
        height: 100vh;
        justify-content: space-between;
        opacity: 1;
        transition: 0.5s;
    }

    #fixedOverlay .scroll-wrapper .scroll-area {
        height: 100%;
        width: 5vw;
        display: flex;
        align-items: center;
        justify-content: center;
    }

    @media screen and (max-width: 767px) {
        #fixedOverlay .scroll-wrapper .scroll-area {
            width: 10vw;
        }
    }

    #fixedOverlay .scroll-wrapper .scroll-area#sidebar-wrapper #scrollbar-container {
        width: 30%;
        height: 30%;
        background-color: rgba(98, 129, 239, 0.3);
        border-radius: 10px;
        max-width: 7px;
    }

    #fixedOverlay .scroll-wrapper .scroll-area#sidebar-wrapper #scrollbar-container #scrollbar {
        width: 100%;
        background: #002060;
        opacity: 100%;
        height: 0%;
        border-radius: 20px;
        transition: background-color 0.5s;
    }

    #fixedOverlay nav {
        box-sizing: border-box;
        z-index: 2;
        pointer-events: none;
        display: block;
        transition: 0.5s;
        height: 87px;
    }
</style>

<!-- back to top -->
<style>
    #BacktoTop {
        display: none;
        position: fixed;
        bottom: 20px;
        right: 30px;
        z-index: 99;
        font-size: 18px;
        border: none;
        outline: none;
        background-color: #B8EBFF;
        color: white;
        cursor: pointer;
        padding: 15px;
        border-radius: 30%;
    }

    #BacktoTop:hover {
        background-color: #002060;
    }

    .indexbutton {
        display: none;
        color: #FAFAFC;
        text-transform: capitalize;
        font-size: 1.4rem;
        width: 100%;
        text-align: center;
        font-weight: bold;
        padding: 16px 0;
        height: 62px;
        box-sizing: border-box;
        cursor: pointer;
        background-color: #6281EF;
        z-index: 21;
        transition: 0.5s;
    }

    @media (max-width: 800px) {
        .indexbutton {
            display: block;
        }
    }
</style>

<!-- in page menu -->
<style>
    .sideBlock {
        text-transform: uppercase;
        text-decoration: none;
        float: left;
        margin-left: 10vw;
        margin-top: 400px;
        position: -webkit-sticky;
        position: fixed;
        top: 30%;
        margin: 200px 32px 0 4vw;
        transform: translateY(-50%);
        min-width: 20px;
        max-width: 350px;
        background: #ffffff;
        opacity: 80%;
        border-radius: 15%;
        padding-left: 20px;
        z-index: 2;
    }

    @media (max-width: 1024px) {
        .sideBlock {
            margin: 200px 32px 0 4vw;
        }
    }

    .sideBlock b {
        font-size: 1.4rem;
        font-weight: bold;
        margin-left: 0.25em;
        padding-bottom: 20px;
        display: block;
    }

    .sideBlock ul {
        margin: 1em 0;
        padding: 0;
    }

    .sideBlock a {
        color: #002060;
        text-decoration: none;
        font-family: "lato-light", sans-serif;
    }

    .sideBlock li {
        margin: 24px;
        list-style: none;
        color: #002060;
        font-size: 1.1rem;
        cursor: pointer;
        display: flex;
        align-items: center;
        margin-left: 0.25em;
    }

    .sideBlock li:last-child {
        margin-bottom: 0;
    }

    .sideBlock li div {
        max-width: 15px;
        max-height: 15px;
        box-sizing: border-box;
        border: 1px solid;
        color: #002060;
        border-radius: 2px;
        transition: 0.5s;
        margin-right: 8px;
        height: 10vw;
        width: 10vh;
    }

    .sideBlock li.active div {
        background-color: #002060;
    }

    #content {
        padding: 0px;
        width: 100%;
        margin-top: -7px;
        margin-left: 0px;
        border: none;
        line-height: initial;
    }
</style>

<!-- text wrapper -->
<style>
    #content-tag {
        background-color: #ffffff;
        position: relative;
    }

    .content p.photo-desc {
        text-align: center !important;
        font-size: 14px !important;
    }

    #content-tag p {
        margin: 0;
        font-size: 1.2rem;
        line-height: 1.5;
        margin-top: 20px;
        margin-bottom: 20px;
        text-align: justify;
    }

    #content-tag .contentBlock {
        float: none;
        margin: 0 auto;
    }

    #content {
        padding: 0px;
        width: 100%;
        margin-top: -7px;
        margin-left: 0px;
        border: none;
        line-height: initial;
    }

    .contentBlock {
        width: 64vw;
        max-width: 1000px;
        /*change box size*/
        float: right;
        display: flex;
        flex-direction: column;
    }

    .content {
        padding: 64px;
        border-radius: 5px;
        box-shadow: 0 0 10px lightgray;
        color: #121212;
        margin-top: 40px;
        overflow: hidden;
        display: flex;
        flex-direction: column;
        flex: 1 0 auto;
    }


    .content p:first-child {
        margin-top: 0;
    }


    .content ul {
        padding-inline-start: 20px;

        list-style-image: none;
        list-style-type: none;
    }

    .content ul li {
        display: flex;
        font-size: 1.2rem;

    }

    .content ol li {
        font-size: 1.2rem;

    }

    .content ul li::before {
        font-size: 1.2rem;
        color: #000000;
    }

    .content .splide ul li::before {
        content: unset;
    }

    .content li {
        margin: 10px;
    }

    .content li::marker {
        color: #000000;
        font-size: 1.3em;
    }

    .content h4,
    .content h5 {
        font-size: 1.2em;
        text-transform: uppercase;
        margin-block-end: 0.2em;
        margin-block-start: 30px;
    }

    .content h5 {
        font-size: 1.2rem;

    }

    .content a {
        color: #2e64ec;
        text-decoration: none;
        text-align: center;
        cursor: pointer;
    }

    .content a.citation {
        font-size: 0.6em;
        vertical-align: super;
    }

    .content-paragraph {
        margin: 0;
        font-size: 1.2rem;
        line-height: 1.5;
        margin-top: 20px;
        margin-bottom: 30px;
        text-align: justify;
    }
</style>

<!-- slideshow -->
<style>
    /* Slideshow container */
    .slideshow-container {
        max-width: 300px;
        position: relative;
        margin: auto;
        border: 4px solid #CEDDEF;
    }

    /* Next & previous buttons */
    .prev,
    .next {
        cursor: pointer;
        position: absolute;
        top: 50%;
        width: auto;
        padding: 16px;
        margin-top: -22px;
        color: white;
        font-weight: bold;
        font-size: 18px;
        transition: 0.6s ease;
        border-radius: 0 3px 3px 0;
        user-select: none;
        background-color: rgba(0, 0, 0, 0.472);
    }

    /* Position the "next button" to the right */
    .next {
        right: 0;
        border-radius: 3px 0 0 3px;
    }

    /* On hover, add a black background color with a little bit see-through */
    .prev:hover,
    .next:hover {
        background-color: rgba(0, 0, 0, 0.883);
    }

    /* Caption text */
    .text {
        color: #f2f2f2;
        font-size: 15px;
        padding: 8px 12px;
        position: absolute;
        bottom: 8px;
        width: 100%;
        text-align: center;
    }

    /* Number text (1/3 etc) */
    .numbertext {
        color: #f2f2f2;
        font-size: 12px;
        padding: 8px 12px;
        position: absolute;
        top: 0;
    }

    /* The dots/bullets/indicators */
    .dot1 {
        cursor: pointer;
        height: 15px;
        width: 15px;
        margin: 0 2px;
        background-color: #bbb;
        border-radius: 50%;
        display: inline-block;
        transition: background-color 0.6s ease;
    }

    .activeSlide1,
    .dot1:hover {
        background-color: #717171;
    }

    .dot2 {
        cursor: pointer;
        height: 15px;
        width: 15px;
        margin: 0 2px;
        background-color: #bbb;
        border-radius: 50%;
        display: inline-block;
        transition: background-color 0.6s ease;
    }

    .activeSlide2,
    .dot2:hover {
        background-color: #717171;
    }

    /* Fading animation */
    .fade {
        -webkit-animation-name: fade;
        -webkit-animation-duration: 1.5s;
        animation-name: fade;
        animation-duration: 1.5s;
    }

    @-webkit-keyframes fade {
        from {
            opacity: .4
        }

        to {
            opacity: 1
        }
    }

    @keyframes fade {
        from {
            opacity: .4
        }

        to {
            opacity: 1
        }
    }

    /* On smaller screens, decrease text size */
    @media only screen and (max-width: 300px) {

        .prev,
        .next,
        .text {
            font-size: 11px
        }
    }
</style>

<!-- cards -->
<style>
    .card-icon {
        z-index: 1;
    }

    .icon {
        padding: 10%;
        width: 80%;
        margin-left: auto;
        margin-right: auto;
        display: block;
        max-width: 160px;
    }

    .info-section {
        margin: auto;
        margin: 20px;
        text-align: center;
    }

    .cardcolors {
        --bg-color: #5893D4;
        --bg-color-light: #5893D4;
        --text-color-hover: #ffffff;
        --box-shadow-color: #99CED3;
    }

    .c-card {
        margin: auto;
        margin-bottom: 20px;
        margin-right: 100px;
        width: 220px;
        height: 321px;
        background: #fff;
        border-radius: 10px;
        overflow: hidden;
        display: flex;
        flex-direction: column;
        justify-content: center;
        align-items: center;
        position: relative;
        box-shadow: 0 14px 26px rgba(128, 128, 128, 0.2);
        transition: all 0.3s ease-out;
        text-decoration: none;
        font-size: 20px;
        padding: 0px !important;
    }

    .c-card:hover {
        transform: translateY(-5px) scale(1.005) translateZ(0);
        box-shadow: 0 24px 36px rgba(163, 33, 33, 0.11), 0 24px 46px var(--box-shadow-color);
        text-decoration: none;
    }

    .c-card:hover .overlay {
        transform: scale(4) translateZ(0);
    }

    .c-card:hover .circle {
        border-color: var(--bg-color-light);
        background: var(--bg-color);
    }

    .c-card:hover .circle:after {
        background: var(--bg-color-light);
    }

    .c-card:hover p {
        color: var(--text-color-hover);
    }

    .c-card:active {
        transform: scale(1) translateZ(0);
        box-shadow: 0 15px 24px rgba(0, 0, 0, 0.11), 0 15px 24px var(--box-shadow-color);
    }

    .c-card p {
        font-size: 20px;
        color: #5893D4;
        margin-top: 30px;
        z-index: 8;
        transition: color 0.3s ease-out;
        text-decoration: none;
    }

    .circle {
        width: 162px;
        height: 162px;
        border-radius: 60%;
        background: #fff;
        border: 2px solid var(--bg-color);
        display: flex;
        justify-content: center;
        align-items: center;
        position: relative;
        z-index: 1;
        transition: all 0.3s ease-out;
    }

    .circle:after {
        content: "";
        width: 160px;
        height: 160px;
        display: block;
        position: absolute;
        background: var(--bg-color);
        border-radius: 50%;
        transition: opacity 0.3s ease-out;
    }

    .circle svg {
        z-index: 10000;
        transform: translateZ(0);
    }

    .overlay {
        width: 118px;
        position: absolute;
        height: 118px;
        border-radius: 50%;
        background: var(--bg-color);
        top: 70px;
        left: 50px;
        z-index: 0;
        transition: transform 0.3s ease-out;
    }

    .front-cover {
        width: 100%;
        height: 100vh;
    }
</style>

<!-- header text -->
<style>
    .header h1 {
        font-size: 50px;
        margin-block-end: 0;
        color: #1F3C88;
        font-family: "raleway", sans-serif !important;
        padding-bottom: px;
    }

    .header h2 {
        margin-block-start: 0;
        font-family: "raleway", sans-serif !important;
        text-transform: uppercase;
        font-size: 30px;
        color: #5893D4;
    }
</style>

<!-- line -->
<style>
    hr.line {
        border-top: 8px solid #bbb;
        border-radius: 2px;
        border-color: #CEDDEF;
    }
</style>

<body>
    <!-- basic elements -->

    <!-- loader -->
    <div id="loader-wrapper">
        <div id="loader-bg">
            <img src="https://2021.igem.org/wiki/images/b/bb/T--Greece_United--loader.gif" />
        </div>
    </div>
    <!-- header -->
    <img src="https://2021.igem.org/wiki/images/2/2c/T--Greece_United--header-hp.png" class="banner">

    <!-- navigation bar -->
    <div style="display: flex;flex-wrap: wrap;background-color:#002060;position: fixed;top: 0;width: 100%;z-index: 10;">
        <div style="padding: 14px 20px;
            display: flex;
            cursor: pointer;">
            <a href="https://2021.igem.org/Team:Greece_United" class="active">


                <img style="height: 70px;background-size: cover;padding-right: 7px;position: relative;padding-top:20px;"
                    src="https://2021.igem.org/wiki/images/a/a2/T--Greece_United--logo-small-transp-cropped.png">
            </a>
        </div>

        <div class="right-navbar">
            <ul id="nav" style="display: flex;flex-direction: row;list-style: none inside;margin: 0;padding: 0;">

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United'">HOME</a>
                        </button>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Description'">PROJECT</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Description">DESCRIPTION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Implementation">IMPLEMENTATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Engineering">ENGINEERING</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Results">RESULTS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Impact">IMPACT</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Contribution">CONTRIBUTION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Partnership">PARTNERSHIP</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Graphics">GRAPHICS</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Design'">WET LAB</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Design">DESIGN</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Experiments">EXPERIMENTS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Notebook">NOTEBOOK</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Part_Collection">PART COLLECTION</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Model'">DRY LAB</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Model">MODEL</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Model/App">APPLICATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Model/Circuit">GENETIC CIRCUIT</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Human_Practices'">HUMAN
                            PRACTICES</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Human_Practices">HUMAN PRACTICES</a>

                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Education">EDUCATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Communication">COMMUNICATION</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Collaborations">COLLABORATIONS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Inclusivity">INCLUSIVITY</a>
                        </div>
                    </div>
                </li>

                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 16px;background-color: inherit;font-family: inherit;margin: 0;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Entrepreneurship'">
                            ENTREPRENEURSHIP</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Entrepreneurship">ENTREPRENEURSHIP</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Entrepreneurship/MarketAnalysis">MARKET
                                ANALYSIS</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Entrepreneurship/StrategicPlanning">STRATEGIC
                                PLANNING</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Entrepreneurship/ProductDescription">PRODUCT
                                DESCRIPTION</a>
                        </div>
                    </div>
                </li>
                <li>
                    <div class="dropdown" style="float: left;">
                        <button
                            style="font-size: 1.2em;border: none;outline: none;color: white;padding: 14px 17px;background-color: inherit;font-family: inherit;margin-right: 50px;z-index: 10;"
                            onclick="location.href = 'https:\/\/2021.igem.org/Team:Greece_United/Team'">TEAM</a>
                        </button>
                        <div class="dropdown-content">
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Team">TEAM</a>
                            <a onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Attributions">ATTRIBUTIONS</a><a
                                onmouseover="changeColor(this)" onmouseout="normalColor(this)"
                                href="https://2021.igem.org/Team:Greece_United/Sponsors">SPONSORS</a>
                        </div>
                    </div>
                </li>
            </ul>
        </div>
    </div>


    <!-- Back to Top Button -->
    <button onclick="topFunction()" id="BacktoTop" title="Go to top">
        <svg width="24" height="24" viewBox="0 0 24 24">
            <path d="M0 16.67l2.829 2.83 9.175-9.339 9.167 9.339 2.829-2.83-11.996-12.17z" />
        </svg>
    </button>
    <!-- Back to Top Button End-->

    <!-- Progress bar -->
    <div id="globalWrapper">
        <div id="fixedOverlay" bg="none">
            <div class="scroll-wrapper">
                <div id="sidebar-wrapper" class="scroll-area">
                    <div id="scrollbar-container">
                        <div id="scrollbar" style="height: 3%;"></div>
                    </div>
                </div>

            </div>
        </div>
    </div>
    <!-- Progress bar End -->

    <!-- in page menu -->
    <div id="index" class="sideBlock">
        <div id="indexbutton" class="indexbutton"></div>

        <!-- <b>Human Practices</b> -->
        <ul>
            <li class="active">
                <div></div>
                <a href="#heading1">Overview</a>
            </li>
        </ul>
        <ul>
            <li class="active">
                <div></div>
                <a href="#heading2">Integrated <br>Human Practices</a>
            </li>
        </ul>
        <ul>
            <li class="active">
                <div></div>
                <a href="#heading3">Formulating<br> the Idea</a>
            </li>
        </ul>
        <ul>
            <li class="active">
                <div></div>
                <a href="#heading4">Refining the Design</a>
            </li>
        </ul>
        <ul>
            <li class="active">
                <div></div>
                <a href="#heading5">Towards <br>Implementation</a>
            </li>
        </ul>
        <ul>
            <li class="active">
                <div></div>
                <a href="#heading6">Enterpreneurship</a>
            </li>
        </ul>
    </div>

    <!-- end of basic elements -->

    <!-- human overview -->
    <div id="heading1">
        <div style=" margin-left:300px; margin-top: 50px;" id="content-tag">
            <div class="contentBlock">
                <div class="content">
                    <!-- <h2><b>Human Practices</b></h2><br> -->
                    <div class="header">
                        <h1>Human Practices</h1>
                        <h2>Overview</h2>
                    </div>
                    <p class="content-paragraph">
                        First, we are born. Life around us seems quirky and to
                        explore it, we are tought how to walk. From the moment we take
                        the first step, we constantly think about the next, how to move forward.
                        Each new step brings the urge to make another one, and another one and so we all
                        remain in move. We hope to walk endlessly on this world, however some obstacles we
                        encounter, stop our dreams from being fulfilled. Pain is usually one of them. <br><br>
                        Osteoarthritis is a chronic, debilitating disease that affects over 7% of the population
                        worldwide.<br><br>
                        To provide for <b><i>One Less Painful Step</i></b>, we first had interacted with these patients.
                        The needs, thoughts, and troubles of those who suffer were the driver and the means
                        for a human-centered design.In subsequent stages, the crucial dilemmas were resolved
                        via targeted interviews with experts. Throughout the project we sought communication
                        with the market, potential investors and policy makers to ensure a solid business plan
                        towards a marketable product.<br><br>
                        Interactive science communication events held during the project created numerous
                        opportunities to open dialogue with the society, help us shape a socially acceptable
                        solution and prepare the public to include synthetic biology into everyday life.<br><br>
                        It was a unanimous decision amongst all team members to engage in educational activities
                        throughout the project and create opportunities for audiences in all learning levels:
                        from kindergarten to higher education and lifelong learning. Communicating science was
                        fulfilling; discussing and debating synthetic biology was exhilarating! Reflecting upon
                        this experience we now realize that each person has a different perspective, but science
                        can be our common denominator<br><br>
                        For better science and better society, none should be left out. Among those
                        with less than equal representation in sciences, we identified three main groups
                        to engage: refugees, women, and artists.<br><br>
                    </p>
                </div>
            </div>
        </div>
    </div>
    <br><br><br>

    <!-- cards -->
    <div class="info-section" style="margin-left:370px;">

        <div class="container ">
            <div class="row">
                <div class="col-xl-3 col-md-6 col-xs-12" style="display:inline-block;">
                    <a href="https://2021.igem.org/Team:Greece_United/Human_Practices#heading2"
                        class="c-card cardcolors">
                        <div class="overlay"></div>
                        <div class="circle">
                            <img src="https://2021.igem.org/wiki/images/8/86/T--Greece_United--hp-card-integrate.png"
                                alt="HP Icon" class="icon card-icon" />
                        </div>
                        <p> Integrated Human Practices</p>
                    </a>
                </div>
                <div class="col-xl-3 col-md-6 col-xs-12" style="display:inline-block;">
                    <a href="https://2021.igem.org/Team:Greece_United/Education" target="_blank"
                        class="c-card cardcolors">
                        <div class="overlay"></div>
                        <div class="circle">

                            <img src="https://2021.igem.org/wiki/images/8/86/T--Greece_United--hp-card-edu.png"
                                alt="Bio Icon" class="icon card-icon" />
                        </div>
                        <p>Education</p>
                    </a>
                </div>
                <div class="col-xl-3 col-md-6 col-xs-12" style="display:inline-block;">
                    <a href="https://2021.igem.org/Team:Greece_United/Communication" target="_blank"
                        class="c-card cardcolors">
                        <div class="overlay"></div>
                        <div class="circle">
                            <img src="https://2021.igem.org/wiki/images/3/35/T--Greece_United--hp-card-communication.png"
                                alt="Bio Icon" class="icon card-icon" />
                        </div>
                        <p>Public Engagement</p>
                    </a>
                </div>
            </div>
            <div class="row">
                <div class="col-xl-3 col-md-6 col-xs-12 " style="display:inline-block;">
                    <a href="https://2021.igem.org/Team:Greece_United/Inclusivity" target="_blank"
                        class="c-card cardcolors">
                        <div class="overlay"></div>
                        <div class="circle">
                            <img src="https://2021.igem.org/wiki/images/e/ec/T--Greece_United--hp-card-inclu.png"
                                alt="HP Icon" class="icon card-icon" />
                        </div>
                        <p>Inclusivity</p>
                    </a>
                </div>
                <div class="col-xl-3 col-md-6 col-xs-12 " style="display:inline-block;">
                    <a href="https://2021.igem.org/Team:Greece_United/Collaborations" target="_blank"
                        class="c-card cardcolors">
                        <div class="overlay"></div>
                        <div class="circle">
                            <img src="https://2021.igem.org/wiki/images/5/50/T--Greece_United--hp-card-collab.png"
                                alt="HP Icon" class="icon card-icon" />
                        </div>
                        <p>Collaborations</p>
                    </a>
                </div>
                
            </div>
        </div>
    </div>

    <!-- integrated overviwe -->
    <div id="heading2">
        <div style="margin-top: 200px; margin-left:300px;" id="content-tag">
            <div class="contentBlock">
                <div class="content">
                    <!-- <h2><b>Integrated Human Practices</b></h2> -->
                    <div class="header">
                        <h1>Integrated</h1>
                        <h2>Human Practices</h2>
                    </div>
                    <p class="content-paragraph">The love of science and the desire for
                        impact brought us together in the NOUS team. One simple goal: to
                        create new science and solve a real-world problem. <br><br>
                        However, our first real problem was …to find a problem to solve.
                        After many brainstorming sessions and thanks to the intervention of
                        our mentors, we set up the following strategy. <br><br>
                        Each team member formulated a real-world problem them thought to be
                        important and interesting. All problems were to be briefly analyzed and
                        presented along three aspects: the impact to society, the potential to engage
                        synthetic biology for the solution, and the opportunities to reach the market. <br><br>

                        A first deliberation on more than 10 problems-to-be-solved led us to retain 3 finalists.
                        The team split in 3, each group undertaking to further research and develop the idea and sketch
                        a propose solution. After a long and painful debate, we got our winner: find a cure for
                        osteoarthritis! <br><br>
                        This first internal brainstorming also produced the realization that our team’s collective
                        expertise is
                        not enough to guarantee success. One cannot solve a real-world problem without engaging and
                        interacting
                        with the problem and the world!<br><br>
                        Hence, during our journey we reached out to patients, experts, professionals and entrepreneurs
                        placing
                        our questions and digesting input to <br><br>
                        ­ <b>•</b> to formulate the idea from the patient’s perspective <br>
                        ­ <b>•</b> to refine the design and the experimental procedure with the help of experts <br>
                        ­ <b>•</b> to prepare for real-world implementation considering options for translation from the
                        lab to the patient<br>
                        ­ <b>•</b> to plan for a product that will hit the market <br><br>
                        <b>Here is how we integrated the patients, the experts, the professional and the entrepreneurs
                            throughout our project:</b>
                    </p>
                </div>
            </div>
        </div>
    </div>

    <!-- integrated 1 -->
    <div id="heading3">
        <div style="margin-top: 100px; margin-left:300px;" id="content-tag">
            <div class="contentBlock">
                <div class="content">
                    <!-- <h2><b>Formulating the Idea</b></h2><br> -->
                    <div class="header">
                        <h1>Formulating</h1>
                        <h2>the Idea</h2>
                    </div>
                    <p class="content-paragraph">
                        <b>Contact with the Hellenic League Against Rheumatism (EL.AN. A.).</b><br>
                        <b>Date: April 03, 2021</b><br>
                        <b>Major Issue:</b> Identify important patient requirements for an osteoarthritis treatment.<br>
                        <b>Resolution:</b> Strive for a solution that will be cheap and will require minimum visits to
                        the doctor.<br><br>
                        During our communication with the society, we had the opportunity to get in touch with patients
                        and get a first realistic picture of their lifestyle. In addition, through the discussion with
                        patient representatives we were exposed to the psychological, social and economic impact of the
                        disease on the life of the patient.<br><br>
                        All of this prompted us to review the implementation as we understood more clearly what the
                        financial incentives would be for a new treatment.<br><br>

                        We also took into account in our project design the need of several patients to limit their
                        visits to their treating physician as it was a process with a special psychological burden for
                        them.<br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/7/75/T--Greece_United--ihp-eleana.png" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Logo of organization EL.AN.A </b></p><br><br><br>

                    <p>
                        <b>Contact with the Skeletal Health Association “Butterfly”</b><br>
                        <b>Date: April 06, 2021</b><br>
                        <b>Major Issue:</b> Identify important patient requirements for an osteoarthritis treatment.<br>
                        <b>Resolution:</b> Strive for a solution to halt disease progress before the end stage of
                        paralysis.<br><br>


                        We were given the opportunity to attend a webinar organized by the Association on
                        the subject of osteoarthritis. There, we met the scientific leaders of the association
                        and held an interview with Ms. Tatiana Drakopoulou, Communications Manager of the Skeletal
                        Health Association "Butterfly".<br><br>
                        During the online communication, we were given the opportunity to present our idea to an
                        audience suffering from musculoskeletal disorders including people with osteoarthritis.
                        Patients shared with us their concerns, especially about whether the possibility of complete
                        paralysis could be reduced or eliminated with our proposed treatment.<br><br>

                        Finally, the club published about us on its website and on social media and so we were
                        able to gradually get in touch with a growing audience of osteoarthritis patients.<br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/d/dc/T--Greece_United--ihp-petalouda.png" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Logo of Skeletal Health Association “Butterfly” </b></p><br><br>
                    <p>
                        Link of the article (Greek) in <a href="https://osteocare.gr/έρευνα-οστεοαρθρίτιδα-igem-nous/">
                            Osteocare Website.</a>
                    </p>
                </div>
            </div>
        </div>
    </div>

    <!-- integrated 2 -->
    <div id="heading4">
        <div style="margin-top: 100px; margin-left:300px;" id="content-tag">
            <div class="contentBlock">
                <div class="content">
                    <!-- <h2><b>Refining the Design</b></h2><br> -->
                    <div class="header">
                        <h1>Refining</h1>
                        <h2>the Design</h2>
                    </div>
                    <p class="content-paragraph">
                        <b>Call with Prof. George Skretas</b><br>
                        <b>Date: May 11, 2021</b><br>
                        <b>Major Issue:</b> What is the best way to produce exosomes carrying a certain type of
                        miRNA.<br>
                        <b>Resolution:</b> Genetically modify a certain cell so that the cell itself produces the
                        exosomes with the miRNAs of interest inside them!<br><br>


                        George Skretas is a Research Associate Professor and head of the Laboratory of Enzyme &
                        Synthetic Biotechnology at the Institute of Chemical Biology of National Hellenic Research
                        Foundation.<br><br>
                        During an online meeting we discussed exosome production. Some excerpts from the interview:
                        <i>“What do you think is the right way to produce exosomes, with certain type of miRNA inside
                            them?”</i><br><br>

                        “There are two ways that you can use exosomes in order to administer side specifically certain
                        miRNAs.
                        One way is to genetically modify the certain cell – type so that the cell itself produce the
                        exosomes with
                        the miRNAs of interest inside them. The other way is to produce artificial exosomes, insert the
                        certain molecules
                        of interest inside them and administer them again side specifically.”<br><br>
                        He also told us that we can try to run our project with the second way, because it’s more simple
                        and less complicated. <br><br>
                        “However, in this alternative there is the downside that ingenuity and synthetic biology
                        component are reduced and maybe it is something
                        that will affect you, given the competitiveness of the therapies.”<br><br>
                        Based on this discussion, we ruled out the possibility of producing artificial exosomes,
                        and so the idea of using the guiding tag to produce biogenic exosomes was now the one that
                        prevailed. Of course,
                        in the next step we had to learn more about the management of EVs (extracellular vesicles) by
                        experts and experienced in the field.<br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/3/3b/T--Greece_United--ihp-skretas.png" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Screenshot of our meeting with G. Skretas </b></p><br><br><br>

                    <p>
                        <b>Theme: Call with George Niotis</b><br>
                        <b>Date: Friday, May 21, 2021</b><br>
                        <b>Major Issue:</b> Working with exosomes.<br>
                        <b>Resolution:</b> Try to avoid exosomes carrying DNA. Although difficult to insert a genetic
                        circuit, mesenchymal stem cells might do the trick!<br><br>


                        George Niotis is PhD student at George Garinis’ lab at Foundation for Research and Technology,
                        Heraklion,
                        Greece. His scientific interests are mainly focused on exosome research.<br><br>
                        Firstly, we discussed on the use of extracellular mesenchymal stem cells to transfer the circuit
                        to the joint
                        cells versus the use of whole mesenchymal stem cells. We wanted to clarify if it is appropriate
                        to use exosomes
                        to transport DNA molecules, which we want to have satisfactory expression rates in the cells
                        where they will end up.<br><br>

                        He informed us that an exosome with DNA inside is more difficult to achieve expression rates in
                        the target
                        cell. So, this method was excluded.<br><br>
                        We also understood that exosomes are produced at specific rates depending on
                        the cell type. The presence of a protein in the membrane or inside the exosome depends
                        mainly on its concentration within the cell.<br><br>
                        The part that concerned us the most was the laboratory isolation of the EVs. Exosomes are
                        isolated mainly with the ultracentrifuge but there is another method with magnetic beads.
                        However,
                        after the discussion and the services available in our own laboratory, we decided to use a
                        different
                        protocol with the use of a suitable kit.<br><br>
                        Finally, he gave us an indication that it is difficult to put the whole genetic circuit
                        into mesenchymal stem cells, but with this approach he was optimistic that you can isolate
                        exosomes with the guiding tag and miRNA.<br><br>
                        <br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/e/e9/T--Greece_United--ihp-niotis.png" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Screenshot from our meeting with G. Niotis</b> </p><br><br>
                </div>
            </div>
        </div>
    </div>

    <!-- integrated 3 -->
    <div id="heading5">
        <div style="margin-top: 100px; margin-left:300px;" id="content-tag">
            <div class="contentBlock">
                <div class="content">
                    <!-- <h2><b>Towards Implementation</b></h2><br> -->
                    <div class="header">
                        <h1>Towards</h1>
                        <h2>Implementation</h2>
                    </div>
                    <p class="content-paragraph">
                        <b>Contact with a Greek MP</b><br>
                        <b>Date: July 17, 2021</b><br>
                        <b>Major Issue:</b> How can a new treatment be supported by public insurance?<br>
                        <b>Resolution:</b> The chances are greater with an effective and cheaper solution.<br><br>


                        Christos A. Dermentzopoulos is a Lawyer and Member of the Hellenic Parliament.<br><br>
                        The primary reason for our communication with a representative of the Greek Parliament was
                        to try to understand whether a proposed treatment could be supported by the state. In addition,
                        we wanted to know if the state could set up structures so that people with osteoarthritis could
                        receive our proposed treatment more directly.<br><br>

                        He informed us that state records report that about 1 to 1.5 million people suffer from the
                        disease
                        in Greece. After EOF (the FDA Greek equivalent) clearance, an effective treatment would be
                        quickly
                        considered for inclusion in the public insurance reimbursement scheme, especially if it is
                        affordable. <br><br>
                    </p>   
                    
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/7/77/T--Greece_United--dermetzopoulos.jpg" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Photo from our meeting with C. A. Dermentzopoulos</b> </p>
                    
                    <br><br><br>


                    <p class="content-paragraph">

                        <b>Discussion with a biotech company on alternative technologies for tissue engineering</b><br>
                        <b>Date: September 03, 2021</b><br>
                        <b>Major Issue:</b> Using a gel to hold and deliver mesenchymal stem cells via injection.<br>
                        <b>Resolution:</b> A gel CAN be used to hold and deliver the proposed therapy. This opens the
                        opportunity for an injectable delivery rather than surgical placement. <br><br>


                        “ClexBio” is a biotech company that is looking for solutions for tissue engineering and
                        single – cell techniques. “ClexBio” focuses mainly on microfluidics and hydrogel technologies.
                        In our contact with the company, we had the opportunity to talk with Tia Tidwell who is a Lead
                        Scientist at Translational
                        Research sector of the company.<br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/9/9a/T--Greece_United--ihp-tia.png" target="_blank"
                        width="200px">
                    <p class="photo-desc"><b> Tia Tidwell: Lead Scientist - Translational Research</b></p>
                    <br><br>

                    <p>
                        The company is currently considering approaches that include spheroids and microbeads.
                        After presenting our approach to Ms. Tidwell, we were given the opportunity to solve some
                        questions regarding the implementation of the proposed therapeutic approach. Our concerns
                        on the company’s technology and the way that we could use it were the following:<br><br>

                        <b>•</b> Can mammalian cells and mesenchymal stem cells in particular fit and survive inside the
                        microbeads of a gel? <br>
                        ­<b>•</b> Could this technology evolve in injectable form? <br>
                        ­<b>•</b> To what extent do cells communicate with the environment? Are they metabolically
                        active?<br>
                        ­<b>•</b> What is the degree of toxicity caused by currently available gels in neighboring
                        cells?<br><br>

                        In the discussion that followed, we realized that the size of the alginate microbeads is ideal
                        so that the
                        cells that we are using can be administered via this gel. In fact, this technology already has
                        the potential to evolve into something injectable.<br><br>
                        Also, it was confirmed that the cells inside this bio-gel maintain an adequate viability and
                        communication with the neighboring cells, making it ideal for our idea. There is no concern
                        regarding
                        the toxicity of this gel for the human body as it is specifically designed with biomaterials for
                        this
                        purpose. the well-tolerated environment of the gel and the very good communication of the cells
                        around
                        and through it allow its use. <br><br>
                        The only remaining concern is that although an adequate viability of the cells is maintained,
                        the cells seem to go through a quiescent phase. However, this is something that, according to
                        Ms.
                        Tidwell, is still under research, with very promising progress being achieved. Even though this
                        bio-gel
                        has not been clinically approved yet, it is a very good prospect to combine with our proposed
                        treatment
                        method as it is expected to be approved soon.<br><br>
                        In this way, our idea began to take on a new trajectory, regarding the means of administration.
                        Our approach so far included the surgery of the patient. However, the potential of this
                        technology
                        combined with our project, makes it more painless and less time consuming to rehabilitate the
                        patient
                        making an injectable form possible.<br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/c/c5/T--Greece_United--ihp-tia-screen.png"
                        target="_blank" width="400px">
                    <p class="photo-desc"><b> Screenshot from our meeting with T. Tidwell</b> </p><br><br>


                    <p>
                        <b>Discussion with a microbiologist</b><br>
                        <b>Date: September 23, 2021</b><br>
                        <b>Major Issue:</b> How and where to place the final envisaged product? <br>
                        <b>Resolution:</b> Preferably a minimally invasive kit for outpatient use. Preferably separate
                        diagnostic and therapeutic kit, so as to diversify marketing.<br><br>


                        The envisaged final product of the proposed method is a medical kit with all the biological
                        parts required for the delivery of the solution to the osteoarthritic joint (either
                        transdermally or via injection).<br><br>

                        Therefore, we visited a practicing microbiologist Dr. Fotini Sopasi to better understand the
                        management
                        of diagnostic and therapeutic kits and their positioning in the market.<br><br>
                        Could such a kit be picked up from your own clinic and later proceed with a patient's treatment
                        protocol?<br><br>
                        “Well, the legislation in Greece requires doctors of the respective specialty to manage the
                        diagnosis or treatment of
                        a specific disease. The final envisaged kit of the treatment you are investigating would be
                        prescribed and handled
                        in cooperation with a specialist orthopedist.<br><br>
                        For a diagnostic or therapeutic kit to hit the market for use directly by the patient means that
                        the kit
                        is easy to use and is as non-invasive as possible.<br><br>
                        In a diagnostic laboratory like this one, we could certainly undertake the diagnosis part of
                        your proposed solution.”<br><br>
                        Question: “How feasible would it be for diagnostic laboratories like yours to work with
                        orthopedic experts for the
                        early diagnosis of osteoarthritis by recognizing certain exosomes that are considered to be
                        biomarkers?”<br><br>
                        “Well, the idea of biomarkers is inevitably something that would give impetus to the early
                        diagnosis of osteoarthritis.
                        However, to be honest, my own laboratory at the moment does not have the necessary equipment for
                        the characterization of exosomes,
                        but it is something that I am sure that other colleagues would agree to invest in and promote in
                        their daily practice, if
                        these biomarkers are promising”.<br><br>
                    </p>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/3/33/T--Greece_United--romanidou.jpg" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Photo from our visit to the laboratory of Ms. Sopasi -
                        Romanidou</b></p><br><br>
                </div>
            </div>
        </div>
    </div>

    <!-- integrated 4 -->
    <div id="heading6">
        <div style="margin-top: 100px; margin-left:300px; padding-bottom: 100px;" id="content-tag">
            <div class="contentBlock">
                <div class="content">
                    <!-- <h2><b>Enterpreneurship</b></h2><br> -->
                    <div class="header">
                        <h1>Enterpreneurship</h1>
                    </div>
                    <p class="content-paragraph">
                        <b>Discussion with Alexios Kontis</b><br>
                        <b>Date: May 2, 2021</b><br>
                        <b>Major Issue:</b>How to raise funds? What is a business plan?<br>
                        <b>Resolution:</b> A draft layout of the contents of a business plan and what each section
                        means.<br><br>


                        Alexios Kontis is an experienced strategy and operations consultant
                        with more than 25 years of work in the field. We hold various meeting concerning
                        the entrepreneurial aspect of our project seeking for guidance and advice.<br><br>

                        At the beginning, Mr. Kontis helped us to build a solid fundraising plan in order to cover
                        all of our financial needs. His help consisted on advices and feedback on: <br><br>

                        <b>i)</b> our business proposal <br>
                        ­<b>ii)</b> our pitching presentation <br>
                        ­<b>iii)</b> organizing the structure of our fundraising plan<br><br>
                        ­
                        Later on, Mr. Kontis gave us foundational advices concerning our business plan and idea. More
                        specifically,
                        he helped us: <br><br>

                        <b>i)</b> organize the structure of our business plan (sections, content etc.) <br>
                        ­<b>ii)</b> reviewed and gave valuable feedback on the final drafts of our business plan.
                        <br><br>
                        ­
                        To sum up, Mr. Kontis contributed to making us better understand the entrepreneurial world, to
                        help us
                        strategically organize the abovementioned sector and how to detect and take up valuable
                        opportunities in
                        order to implement our business idea.
                    </p>
                    <br><br>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/0/04/T--Greece_United--kontis-integrated.png" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Screenshot from our meeting with Mr. Kontis.</b></p><br><br>

                    <p class="content-paragraph">

                        <b>Discussion with DELOITTE</b><br>
                        <b>Date: September 13, 2021</b><br>
                        <b>Major Issue:</b> Impress one of our biggest sponsors with our progress. Get feedback on
                        methodology of developing a business plan. <br>
                        <b>Resolution:</b> Comments on how to finalize our business plan.<br><br>


                        With 45 years of presence in the Greek market, Deloitte Greece provides consulting, financial
                        advisory, risk advisory,
                        tax & legal, audit & assurance services. Deloitte is one of our big sponsors and we had the
                        opportunity to visit their
                        offices in Thessaloniki, and thus better understand how such a renowned company works.<br><br>

                        At the same time, we met a team consisting of business strategists, market analysts and
                        marketeers and we had the pleasure
                        to conversate with them about the implementation of our therapy. Finally, we met and presented
                        our work to Mr. Kafatos, who
                        is Deloitte Greece Clients & Industries Leader, Head of Strategy Practice and in charge of the
                        Deloitte Alexander
                        Competence Center.<br><br>
                        During the discussion, we discussed best practices on developing a business plan.<br><br>
                    </p>
                    <br><br>
                    <img style="align-self: center;  border-radius: 10px; box-shadow: 5px 5px 14px rgb(83, 83, 83);"
                        src="https://2021.igem.org/wiki/images/d/db/T--Greece_United--deloitte-integrated.jpg" target="_blank"
                        width="400px">
                    <p class="photo-desc"><b> Photo from our visit at Deloitte's premisses in Thessaloniki.</b></p><br><br>

                    <p class="content-paragraph">
                        <b>Discussion with DENIUM</b><br>
                        <b>Date: October 14, 2021</b><br>
                        <b>Major Issue:</b> Looking ahead… Key success predictors while designing a start-up.<br>
                        <b>Resolution:</b> Pay special attention to the people, i.e. the team. Shape your idea and
                        develop a good business plan. <br><br>


                        Demium is an international talent investor company, operating with strong presence in 5 European
                        countries and
                        managing 8 business incubator programs. We had the pleasure to hold two meetings with Mr. George
                        Platanas, Head of the
                        incubation program in Greece.<br><br>

                        During our meetings we pitched our project with the purpose of receiving feedback concerning:
                        <br><br>

                        <b>i)</b> our business idea and team <br>
                        ­<b>ii)</b> the implementation and action plan we have designed.<br>

                        It was very important for us to receive feedback from a company that has great expertise in the
                        field of start-ups.
                        Mr. Platanas helped us understand the importance of a great team, the number of persons that
                        usually make the team so
                        as to work efficiently and the process required to implement our business idea<br><br>
                        Last but not least, Mr. Platanas impressed by our work, saw a promising future for our business
                        idea and thus insists
                        that after the iGEM competition we must enroll in Demium incubation program with the potential
                        of getting pre-seeded and
                        receive a financial support.<br><br><br>
                    </p>
                    <p>
                        <b>Discussion with ELPEN</b><br>
                        <b>Date: October 16, 2021</b><br>
                        <b>Major Issue:</b> Looking ahead… How to design a promising implementation approach<br>
                        <b>Resolution:</b> Should normally get the therapy successfully through clinical trial phase I
                        and II, before looking out for an investment from big pharma. <br><br>


                        ELPEN is a prestigious Greek pharmaceutical company, consisting of more than 600 hundred
                        employers,
                        with strong presence in the Greek and European market and has the largest educational center for
                        translational
                        research in the Balkans. We had the pleasure to communicate with Mr. Verivakis Georgios,
                        Commercial Director of the company.<br><br>

                        We communicated with him in order to have an inside view of how pharmaceutical companies work
                        and how that
                        affects our proposed implementation. After presenting our work and discussing many topics, we
                        understood
                        that for a pharmaceutical company to invest in a therapy, first promising results must be shown
                        and it is
                        common also (as a prerequisite) that the therapy should have passed successfully clinical trials
                        of phase I and II,
                        for the investment to be granted.<br><br>

                        This information changed our thoughts, because our strategic planning consisted of an investment
                        of a pharmaceutical company
                        at the stage of clinical phase I. Although, this made us consider other options for funding
                        during the early stages.<br><br>

                        <br>
                    </p>
                    <p>
                        <b>Participation in ARCIMEDES Business Accelerator </b><br>
                        <b>Date: March to June, 2021</b><br>
                        <b>Major Issue:</b> How to start a start-up? <br>
                        <b>Resolution:</b> A toolbox of best practices, hands-on experience and support on how to start
                        a business around our idea.<br><br>


                        ARCHIMEDES is the acceleration center of National and Kapodistrian University of Athens. Its
                        purpose is to promote
                        entrepreneurship within the University’s community, as well as to support researchers and
                        potential entrepreneurs
                        to develop their ideas and bring them to the market.<br><br>

                        We are glad to have been given the opportunity to participate in the 3rd cycle of ARCHIMEDES
                        acceleration
                        program and have been 1 of the 15 selected teams to enroll. This journey begun in March 19 of
                        2021 and is
                        still ongoing as the program ends in February 2022.<br><br>

                        We have actively participated in all the workshops organized, which really
                        helped us solidify our entrepreneurial idea, learning from experienced businessmen,
                        such as Mr. Siemos Vasilis and Dr. Livieratos Antonis, but also through a process of
                        trial and error. The workshops analyzed and helps us understand crucial entrepreneurial terms
                        (such as the SWOT analysis, the Business model canvas etc.).<br><br>
                        The 1st part of the 3rd cycle of ARCHIMEDES acceleration program concluded in 19th of July
                        giving us the opportunity to pitch
                        our idea to many representatives of “landmark” companies in the Greek market (such as Vodafone
                        Greece) and many investors.<br><br>
                        Today, we are still participating in the 2nd part of the 3rd cycle of ARCHIMEDES acceleration
                        program, which mainly consist of
                        helping the teams build a solid business plan based on their business idea.<br><br>
                        Dr. Dimitrakopoulos Yiannis holds the positions of Adjunct Lecturer at Athens University of
                        Economics and Business and Technology Transfer Office Manager
                        at ARCHIMEDES, acceleration center of National and Kapodistrian University of Athens. <br><br>
                        Because of his field of expertise, we contacted Dr. Dimitrakopoulos in order to get informed
                        about patent
                        regulations and the procedures required. He gave us an insight about how patent agencies and
                        regulations
                        work in Greece and Europe. He also gave us valuable feedback after our project pitching,
                        about:<br><br>
                        <b>i)</b> how to apply for a patent <br>
                        ­<b>ii)</b> which are the most important sections of our project that we should consider
                        patenting<br>
                        ­<b>iii)</b> how we should work with confidentiality, in order to be eligible to apply for a
                        patent.<br><br>

                        All in all, Dr. Dimitrakopoulos has been of great help and importance on developing our business
                        plan and idea. <br><br>
                        <br><br>
                    </p>
                </div>
            </div>
        </div>
    </div>


    <footer class="footer">

        <br><br><br><br>
        <hr style="background-color: #E8E8E8;border: 1.5px solid #E8E8E8;opacity: 50%;">

        <ul>
            <li class="facebook"><a href="https://www.facebook.com/iGEMNous" target="_blank"><i class="fa fa-facebook"
                        aria-hidden="true"></i></a></li>
            <li class="twitter"><a href="https://twitter.com/IgemNous" target="_blank"><i class="fa fa-twitter"
                        aria-hidden="true"></i></a></li>
            <li class="instagram"><a href="https://www.instagram.com/nous_igem/" target="_blank"><i
                        class="fa fa-instagram" aria-hidden="true"></i></a></li>
            <li class="mail"><a href="mailto:igemnous@gmail.com" target="_blank"><i class="fa fa-envelope"
                        aria-hidden="true"></i></a></li>
            <li class="linkedin"><a href="https://www.linkedin.com/company/igem-nous" target="_blank"><i
                        class="fa fa-linkedin" aria-hidden="true"></i></a></li>
            <li class="youtube"> <a href="https://www.youtube.com/channel/UCVN2NQ_uRJVXhXU_FfvKlrg" target="_blank"><i
                        class="fa fa-youtube" aria-hidden="true"></i></a></li>
            <li class="github"><a href="https://github.com/melinazik/iGEM" target="_blank"><i class="fa fa-github"
                        aria-hidden="true"></i></a></li>
            <li class="website"><a href="https://igemnous.med.duth.gr/" target="_blank"><i class="fa fa-globe"
                        aria-hidden="true"></i></a></li>
        </ul>
        <br><br><br><br><br><br><br>
        <hr style="background-color: #E8E8E8;border: 1.5px solid #E8E8E8;opacity: 50%;">

        <br><br><br><br><br><br><br><br>


        <div style="display:flex;flex-wrap:wrap; ">
            <div class="col">
                <a href="https://igemnous.med.duth.gr/" target="_blank">
                    <img style=" position: relative;width: 40%;padding-bottom: 120px;margin-left: calc(100%/1.5);"
                        src="https://2021.igem.org/wiki/images/2/2f/T--Greece_United--black-logo-transp.png">
                </a>

            </div>

            <div style="display: flex;flex-direction: row;justify-content: center;bottom: 0%;">
                <div class="footer_sponsors"
                    style="display: flex;flex: 1;justify-content: center;align-items: center;padding-left: 1%;padding-right: 1%;">
                    <a href="https://duth.gr/" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/5/5f/T--Greece_United--dimokriteio.png"
                            style="width:250%; margin-left: calc((100%)/0.09); margin-bottom: 290px; margin-top: -400px; "></a>
                    <a href="https://www.geneious.com/" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/f/f9/T--Greece_United--geneious.png"
                            style="width:70%; margin-left: calc((100%)/0.45); margin-bottom: 250px; margin-top: -280px;"></a>
                    <a href="https://www2.deloitte.com/gr/en.html" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/0/07/T--Greece_United--deloitte.svg"
                            style="width:170%; margin-left: calc((100%)/0.31); margin-bottom: 290px; margin-top: -480px;"></a>
                    <a href="https://bioemtech.com/" target="_blank"><img
                            src="https://2021.igem.org/wiki/images/6/66/T--Greece_United--bioemtech.png"
                            style="width:40%; margin-left: calc((100%)/6.5); margin-bottom: -40px; margin-top: -320px;"></a>
                </div>
            </div>

        </div>



    </footer>

</body>

<!-- slideshow -->
<script>
    var slideIndex1 = 1;
    var slideIndex2 = 1;
    showSlides1(slideIndex1);
    showSlides2(slideIndex2);

    function plusSlides1(n) {
        showSlides1(slideIndex1 += n);
    }

    function plusSlides2(n) {
        showSlides2(slideIndex2 += n);
    }

    function currentSlide1(n) {
        showSlides1(slideIndex1 = n);
    }

    function currentSlide2(n) {
        showSlides2(slideIndex2 = n);
    }

    function showSlides1(n) {
        var i;
        var slides1 = document.getElementsByClassName("mySlides1");
        var dots1 = document.getElementsByClassName("dot1");


        if (n > slides1.length) {
            slideIndex1 = 1
        }
        if (n < 1) {
            slideIndex1 = slides1.length
        }

        for (i = 0; i < slides1.length; i++) {
            slides1[i].style.display = "none";
        }
        for (i = 0; i < dots1.length; i++) {
            dots1[i].className = dots1[i].className.replace(" activeSlide1", "");
        }
        slides1[slideIndex1 - 1].style.display = "block";
        dots1[slideIndex1 - 1].className += " activeSlide1";
    }

    function showSlides2(n) {
        var i;
        var slides2 = document.getElementsByClassName("mySlides2");
        var dots2 = document.getElementsByClassName("dot2");

        if (n > slides2.length) {
            slideIndex2 = 1
        }
        if (n < 1) {
            slideIndex2 = slides2.length
        }

        for (i = 0; i < slides2.length; i++) {
            slides2[i].style.display = "none";
        }
        for (i = 0; i < dots2.length; i++) {
            dots2[i].className = dots2[i].className.replace(" activeSlide2", "");
        }
        slides2[slideIndex2 - 1].style.display = "block";
        dots2[slideIndex2 - 1].className += " activeSlide2";
    }
</script>


<!-- loader -->
<script>
    // Loader
    window.addEventListener("load", function () {
        let loader = document.getElementById('loader-bg');

        setTimeout(function () {
            loader.classList.add('loaded')
        }, 100);
    });
</script>

<!-- nav bar change color -->
<script>
    function changeColor(x) {
        x.style.background = '#5893D4';
        x.style.color = '#002060';
    }

    function normalColor(x) {
        x.style.background = '#B7E0FF';
    }
</script>

<!-- Back to Top Button -->
<script>
    var mybutton = document.getElementById("BacktoTop");

    window.onscroll = function () {
        scrollFunction()
    };

    function scrollFunction() {
        if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
            mybutton.style.display = "block";
        } else {
            mybutton.style.display = "none";
        }
    }

    function topFunction() {
        document.body.scrollTop = 0;
        document.documentElement.scrollTop = 0;
    }
</script>

<!-- scroll script -->
<script>
    var textSection = null;
    var navbar = document.getElementById("navbar");

    window.addEventListener('load', function () {
        textSection = document.querySelector('.elevate-navbar');
        checkScrollPos();
        checkBackToTopPos();
    })
    window.addEventListener('scroll', function () {
        updateScrollbar();
        checkNavbarPos();
        checkScrollPos();
        checkBackToTopPos();
    });

    function checkScrollPos() {
        var footerTop = document.getElementById("footerWrapper").getBoundingClientRect().top;
        var scrollbarBottom = document.getElementById("scrollbar-container").getBoundingClientRect().bottom;
        let scrollWrapper = document.querySelector('.scroll-wrapper');
        if (scrollbarBottom >= footerTop) {
            if (scrollWrapper.getAttribute("hiddenScroll") == "false") scrollWrapper.setAttribute("hiddenScroll",
                "true");
        } else {
            if (scrollWrapper.getAttribute("hiddenScroll") == "true") scrollWrapper.setAttribute("hiddenScroll",
                "false");
        }
    }

    function checkBackToTopPos() {
        if ($(window).scrollTop() > 1000) {
            $('#backtotop-wrapper').addClass('scrolled')
        } else $('#backtotop-wrapper').removeClass('scrolled')
    }
    $(document).ready(function () {
        $('#backtotop-wrapper').on('click', function () {
            $('html, body').animate({
                'scrollTop': $('body').offset().top
            }, 2000);
        });
    });

    function updateScrollbar() {
        var winScroll = document.body.scrollTop || document.documentElement.scrollTop;
        var height = document.documentElement.scrollHeight - window.innerHeight;;
        var scrolled = (winScroll / height) * 100;
        document.getElementById("scrollbar").style.height = scrolled + "%";
    }

    var scroll = new SmoothScroll('a[href*="#"]', {
        speed: 400,
        speedAsDuration: true,
        offset: 160
    });

    document.getElementById("fixedOverlay").classList.add("project");
</script>

<!-- navigation bar -->
<script>
    function changeColor(x) {
        x.style.background = '#5893D4';
        x.style.color = '#002060';
    }

    function normalColor(x) {
        x.style.background = '#B7E0FF';
    }
</script>

</html>